Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948129 · ClinicalTrials.gov registry record · NA
Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 626
- Enrollment target
NCT00948129: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00948129 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 626 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948129, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 626 participants
- Enrollment target
Study Summary
This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adult smokers.
Interventions
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Tobacco Cessation Counseling
- BEHAVIORAL Telephone-Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 626 participants |
| Start Date | 2009-08-10 |
| Est. Completion | 2021-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00948129
The ClinicalTrials.gov registry entry for NCT00948129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 626 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00948129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00948129 about?
NCT00948129 is a clinical study titled "Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers". This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adu...
What is the current status of trial NCT00948129?
This trial is currently completed. It is a NA study. The enrollment target is 626 participants. The study started on 2009-08-10. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT00948129?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Smoking Cessation Intervention (BEHAVIORAL), Tobacco Cessation Counseling (OTHER), Telephone-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00948129?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.